(19)
(11) EP 1 341 923 A2

(12)

(88) Date of publication A3:
26.06.2003

(43) Date of publication:
10.09.2003 Bulletin 2003/37

(21) Application number: 01950996.7

(22) Date of filing: 10.07.2001
(51) International Patent Classification (IPC)7: C12N 15/85, C12N 15/10, A61K 38/17, A61K 38/19, A61K 39/395, C07K 16/28, C07K 16/24, C07K 16/18, G01N 33/50, C12Q 1/68
(86) International application number:
PCT/US0121/635
(87) International publication number:
WO 0201/8608 (07.03.2002 Gazette 2002/10)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 29.08.2000 US 228914 P
11.01.2001 US 759056
10.07.2001 US 901812

(71) Applicant: GENENTECH, INC.
South San FranciscoCalifornia 94080 (US)

(72) Inventors:
  • TICE, David
    San Mateo, CA 94401 (US)
  • PENNICA, Diane
    Burlingame, CA 94010 (US)
  • POLAKIS, Paul
    Burlingame, CA 94010 (US)
  • SZETO, Wayne
    San Francisco, CA 94107 (US)

(74) Representative: Denison, Christopher Marcus et al
Mewburn EllisYork House23 Kingsway
London WC2B 6HP
London WC2B 6HP (GB)

   


(54) METHODS FOR ENHANCING THE EFFICACY OF CANCER THERAPY